Zydus Cadila to make Gilead’s potential COVID-19 drug remdesivir
NE BUSINESS BUREAU BENGALURU, JUNE 13 Ahmedabad-based drugmaker Zydus Cadila said on Friday it signed a non-exclusive licensing pact with ...
Tag: non-exclusive licensing pact with Gilead Sciences Inc
